tvi-brain-1
Cell therapyexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Apr 1, 2010 (NCT01081223)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, passive
immunity, passive - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tvi-brain-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05685004 | Phase 2/Phase 3 (Phase 3) | Sep 15, 2023 | TVAX Biomedical |
| NCT01290692 | Phase 2 | Jun 1, 2011 | Sponsor GmbH, TVAX Biomedical |
| NCT01081223 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2010 | TVAX Biomedical |
| NCT05936216 | N/A | — | TVAX Biomedical |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| TVAX Biomedical | For profit | 4 | 4 | 3 | 2010 |
| Sponsor GmbH | Academic/Hospital | 1 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1